Understanding Rare Lung Diseases: Why Awareness Saves Lives

Do you have Nontuberculous
Mycobacterial (NTM) Pulmonary Disease?

🫁 Understanding Rare Lung Diseases: Why Awareness Saves Lives

Breathing Shouldn’t Be a Struggle

Most of us don’t think twice about breathing — until something makes it difficult. For people living with rare lung diseases, every breath can be a reminder of how fragile our lungs truly are.

Conditions such as Nontuberculous Mycobacterial (NTM) Lung Disease and Bronchiectasis affect thousands of people in the U.S. and around the world. Yet many remain undiagnosed or misdiagnosed for years.
Raising awareness isn’t just about recognition — it’s about saving lives.

What Makes a Lung Disease “Rare”?

A rare disease is defined in the U.S. as one that affects fewer than 200,000 people. While each rare condition may impact a small number of individuals, together they represent millions of patients who face similar challenges: delayed diagnosis, limited treatment options, and a lack of understanding from both the public and even healthcare professionals.

NTM lung disease, for example, is caused by bacteria found naturally in water and soil. It often develops slowly and can be mistaken for asthma, COPD, or recurring pneumonia.
Bronchiectasis, another chronic lung condition, occurs when the airways become widened and scarred, trapping mucus and creating an environment for bacteria to thrive.

The Power of Awareness

When people recognize the signs and risk factors of rare lung diseases, diagnosis happens sooner — and earlier treatment means better outcomes.
Awareness leads to:

  • Earlier detection: Patients and doctors connect the dots faster.
  • 💬 Better conversations: Individuals feel confident asking questions and seeking specialists.
  • 🌍 More research and funding: Public attention drives investment in better treatments.
  • 💙 Community and support: Patients realize they are not alone.

Every social post shared, story told, and conversation started makes a difference.

How Delayed Diagnosis Affects Patients

For many people with NTM or Bronchiectasis, the journey to diagnosis can take years. Symptoms like chronic cough, fatigue, and shortness of breath often get dismissed as something else.
During that time, infections can worsen, lung function may decline, and emotional health can suffer.

That’s why awareness isn’t just a campaign — it’s a lifeline. The sooner someone recognizes the symptoms and seeks specialized care, the greater their chance of stabilizing or improving their condition.

The Role of Advocacy and Community

Organizations like NTM Info & Research exist to close the gap between patients, physicians, and researchers. By providing education, support groups, and research collaborations, NTMir empowers individuals to take control of their lung health and find community in the process.

Each August 4, the global community comes together for World NTM Awareness Day, a time to honor patient stories, share information, and highlight the urgent need for better care and understanding.

Small Steps, Big Impact

Raising awareness doesn’t require grand gestures. You can help by:

  • Sharing trusted information on social media.
  • Talking openly about your experience or that of a loved one.
  • Encouraging others to learn about rare lung diseases.
  • Supporting NTMir initiatives through donations or fundraising events like Give Miami Day.

When awareness grows, lives are changed — and saved. Donate today to be part of the impact. https://ntminfo.app.neoncrm.com/forms/support-ntm-awareness?campaignId=95

Learn More and Get Involved

If you or someone you love is living with a rare lung condition like NTM or Bronchiectasis, you are not alone.
Visit ntminfo.org to access:

  • Reliable educational resources
  • Patient and caregiver support groups
  • Updates on ongoing research and advocacy efforts

Together, we can help ensure that no one faces a rare lung disease without understanding, hope, and support.

 

220,000

ESTIMATED CASES
OF NTM IN THE US
IN 2020

8.2 %

 THE RISE IN THE
NUMBER OF NTM CASES
EACH YEAR

2.8m

ANTIBIOTIC-
RESISTANT INFECTIONS
IN THE US EACH YEAR